 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | OTOM Co., Ltd. |
| Street 1: | 29, Uchi-ro 880beon-gil |
| Street 2: | |
| City: | Buk-gu |
| Province: | Gwangju |
| Post Code: | 61042 |
| Country: | Republic of Korea |
| Phone: | +82-62-453-7752 |
| Organization Email: | contact@theotom.com |
| Web Site: | http://theotom.com |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | 409-86-19369 |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Health |
| Organization Description: | |
| Our previous name is HDT Co., Ltd. We are a portable X-ray manufacturing company based in Korea. Our CEO, Joon-ho, Oh is a member of steering committee. We are the very first portable x-ray which Korea STOP TB implemented on their screening system and widely contributed to increasing the efficiency and minimizing the missing cases. We also donated our products to WHO collaborating center for TB research called the Pearl study. |
|
| Do you know about the UNHLM declaration: | No |
Specializations / Areas of Work | |
|
Delivery of health services and care |
Other Organization Information | |
| Total number of staff in your organization: | 26 - 50 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 0 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Stop TB communications |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | We were appointed as an official partner of Korea STOP TB. Manager Kang Hee Kim |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | Republic of Korea |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Our device is the only device that is allowed to operate outside under a law of Korean Ministry of Health. Every single regional office in Korea is using our portable X-rays and the demand is increasing each year. Also, now, since they are adopting CAD system, we are also developing AI software to support them even further. Stop TB Korea is not only knocking on the door of people at the shadow of medical services but also contributing to the overall pandemic control using our products. |
|
Geographical Reach | |
| Which country is your headquarters located in: | Republic of Korea |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Republic of Korea |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Delivery of screening services to those who are not receiving the optimal medical care or not eligible for social insurance has become much more efficient. Since Korea Stop TB adopted portable x-ray system, they can visit people rather than calling them around to gather. They use our portable x-rays at least 100 times/day and the demand is even more increasing. New Diagnostics: Increase in portability coupled with an artificial intelligence program increased the work load that each team can handle each day. By screening using chest X-ray and AI software, some process of the whole diagnostic system has been accelerated. Research: We donated a full set of CAD system to the WHO collaborating center at University of Sydney for the TB research called "the PEARL study." The team is on the Kiribati island where the prevalence is the highest in the world based on the population size. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | March 16, 2022 |
| Last updated: | March 16, 2022 |